Skip to content

Evaluation of Oral Mucositis in Laser Treatment

Evaluation of Oral Mucositis in Treatment with Photobiomodulation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5mfxbkj
Enrollment
Unknown
Registered
2025-11-26
Start date
2024-01-20
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematopoietic stem cell transplantation.

Interventions

This is a two-arm, randomized controlled clinical trial with a parallel interventional design, employing a quantitative approach, exploratory character, and open-label blinding. The sample will be col

Sponsors

Complexo do Hospital das Clínicas da Universidade Federal do Paraná (UFPR)
Lead Sponsor
Universidade Federal do Paraná
Collaborator

Eligibility

Age
5 Years to No maximum

Inclusion criteria

Inclusion criteria: Volunteer patients aged 5 years or older; of both sexes; regardless of weight, height, race, or social condition; who will begin the Hematopoietic Stem Cell Transplantation (HSCT) protocol due to onco-hematological or hematological diseases.

Exclusion criteria

Exclusion criteria: Patients undergoing autologous transplantation who are under 5 years of age; who use photosensitive medications (tetracycline, sulfonamide, retinoic and glycolic acid); as well as patients who present with elevated core temperature (fever); allergies or any alteration in the skin of the face during treatment.

Design outcomes

Primary

MeasureTime frame
The study aims to evaluate the preventive clinical response of oropharyngeal mucositis in patients undergoing hematopoietic stem cell transplantation (HSCT) using extraoral photobiomodulation therapy (EOPT) and intraoral photobiomodulation therapy (IOPT).

Secondary

MeasureTime frame
The severity of mucositis is expected to be assessed using the World Health Organization (WHO) and NCI (National Cancer Institute) scales.;The aim is to evaluate the frequency of oropharyngeal mucositis in patients who received intra- and extraoral TFBM using clinical examination.;Pain levels are expected to be assessed using the Visual Analogue Scale (VAS).;The aim is to evaluate the inflammatory markers present in saliva through the processing and analysis of inflammatory constituents and mediators.;The aim is to evaluate both organic and inorganic salivary constituents.;The aim is to assess the temperature difference in the oral region using thermographic images in areas with and without oropharyngeal mucositis.

Countries

Brazil

Contacts

Public ContactJéssica Noronha

Universidade Federal do Paraná

jessicanoronha@ufpr.br+5541995770782

Outcome results

None listed

Source: REBEC (via WHO ICTRP)